Journal ID (nlm-ta): Ann Clin Transl Neurol
Journal ID (iso-abbrev): Ann Clin Transl Neurol
Journal ID (doi): 10.1002/(ISSN)2328-9503
Journal ID (publisher-id): ACN3
Title:
Annals of Clinical and Translational Neurology
Publisher:
John Wiley and Sons Inc.
(Hoboken
)
ISSN
(Electronic):
2328-9503
Publication date
(Electronic):
01
January
2020
Publication date Collection:
January
2020
Volume: 7
Issue: 1
(
doiID:
10.1002/acn3.v7.1
)
Pages: 139-143
Affiliations
[
1
]
Department of Clinical Neuroscience
Karolinska Institutet
Stockholm
Sweden
[
2
]
Centre for Molecular Medicine
Karolinska University Hospital
Stockholm
Sweden
[
3
]
Departments of Medicine, Biomedicine, and Clinical Research
Neurologic Clinic and Policlinic
University Hospital Basel
University of Basel
Basel
Switzerland
[
4
]
Institute of Environmental Medicine
Karolinska Institutet
Stockholm
Sweden
Author notes
[*]
[*
]
Correspondence
Ali Manouchehrinia, The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Department
of Clinical Neurosciences, Karolinska Institutet, Centre for Molecular Medicine, L8:05,
SE‐171 76 Stockholm, Sweden. Tel: +46 738702423: E‐mail:
ali.manouchehrinia@
123456ki.se
Author information
Article
Publisher ID:
ACN350972
DOI: 10.1002/acn3.50972
PMC ID: 6952306
PubMed ID: 31893563
SO-VID: 6c5f97cc-f1ba-420a-9377-299bd71d23d9
Copyright © © 2019 The Authors.
Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
License:
This is an open access article under the terms of the
http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
Funded by: Novartis , open-funder-registry 10.13039/100004336;
Funded by: Biogen , open-funder-registry 10.13039/100005614;
Funded by: Vetenskapsrådet , open-funder-registry 10.13039/501100004359;
Funded by: AFA Försäkring , open-funder-registry 10.13039/501100002706;
Funded by: Genzyme , open-funder-registry 10.13039/100004329;
Funded by: the Swedish Research Council for Health, Working Live and Welfare
Funded by: the Swedish Brain Foundation , open-funder-registry 10.13039/501100003792;
Funded by: Knut , open-funder-registry 10.13039/501100002614;
Funded by: the Alice Wallenberg Foundation
Funded by: Margaretha af Ugglas Foundation
Funded by: EU Horizon 2020 MultipleMS
Award ID: 733161
Funded by: Sanofi , open-funder-registry 10.13039/100004339;
This work was funded by
Novartis , open-funder-registry 10.13039/100004336; grant ;
Biogen , open-funder-registry 10.13039/100005614; grant ;
Vetenskapsrådet , open-funder-registry 10.13039/501100004359; grant ;
AFA Försäkring , open-funder-registry 10.13039/501100002706; grant ;
Genzyme , open-funder-registry 10.13039/100004329; grant ;
the Swedish Research Council for Health, Working Live and Welfare grant ;
the Swedish Brain Foundation , open-funder-registry 10.13039/501100003792; grant ;
Knut , open-funder-registry 10.13039/501100002614; grant ;
the Alice Wallenberg Foundation grant ;
Margaretha af Ugglas Foundation grant ;
EU Horizon 2020 MultipleMS grant 733161;
Sanofi , open-funder-registry 10.13039/100004339; grant .
